https://www.selleckchem.com/HDAC.html
Clinical trials have shown that many patients with breast cancer with limited sentinel lymph node (SLN) metastatic disease can safely avoid axillary lymph node dissection. Ultra-staging of initially negative SLNs may not confer additional clinical benefit. Despite this, protocols of 'enhanced pathological examination' (EPE) are still widely used. We evaluated the impact of our EPE protocol. If initial SLN HEs are negative, we cut three additional HE levels at 500 µm intervals with two spare sections at each level, to allow for immunohisto
Like
Comment
Share
